News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan Laboratories Inc. (MYL) Declares Quarterly Preferred Stock Dividend


8/1/2008 10:44:13 AM

PITTSBURGH, July 31 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share) payable on August 15, 2008, to holders of preferred stock of record as of August 1, 2008.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest-and highest quality-product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.

CONTACT: Media, Michael Laffin, or Investors, Dan Crookshank, both of
Mylan Inc., +1-724-514-1813

Web site: http://www.mylan.com/


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES